# Dexamethasone and COVID-19 Inpatient Mortality

> **NCT04926571** · — · COMPLETED · sponsor: **Aetion, Inc.** · enrollment: 14105 (actual)

## Conditions studied

- Coronavirus

## Interventions

- **DRUG:** Dexamethasone Oral

## Key facts

- **NCT ID:** NCT04926571
- **Lead sponsor:** Aetion, Inc.
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-01
- **Primary completion:** 2021-08-27
- **Final completion:** 2021-08-27
- **Target enrollment:** 14105 (ACTUAL)
- **Last updated:** 2023-04-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04926571

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04926571, "Dexamethasone and COVID-19 Inpatient Mortality". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04926571. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*